Englerins: A Comprehensive Review

Area of Science:

• Natural product chemistry
• Pharmacology
• Oncology

Background:

• Englerin A (1) was discovered a decade ago and exhibits potent activity in cancer models.
• Numerous chemical, biological, and preclinical studies have been conducted on englerin A and its analogues.
• Research has focused on understanding its mechanism of action and therapeutic potential.

Purpose of the Study:

• To review the published findings on englerin A and its analogues.
• To summarize the chemical synthesis, biological activities, and preclinical data.
• To propose future research directions for clinical development.

Main Methods:

• Literature review of chemical, biological, and preclinical studies.
• Analysis of structure-activity relationships.
• Identification of knowledge gaps and future research needs.

Main Results:

• Comprehensive summary of englerin A's discovery and properties.
• Overview of synthetic strategies and biological evaluations.
• Identification of promising analogues for further development.

Conclusions:

• Englerin A analogues show significant therapeutic potential for kidney cancer.
• Further preclinical research is required to optimize analogues for clinical trials.
• Successful translation to clinical practice requires continued multidisciplinary efforts.